GHDX
Genomic Health, Inc.
GHDX
GHDX
Delisted
GHDX was delisted on the 7th of November, 2019.
267 hedge funds and large institutions have $2.51B invested in Genomic Health, Inc. in 2019 Q1 according to their latest regulatory filings, with 60 funds opening new positions, 104 increasing their positions, 70 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
17% less call options, than puts
Call options by funds: $4.39M | Put options by funds: $5.3M
Holders
267
Holding in Top 10
1
Calls
$4.39M
Puts
$5.3M
Top Buyers
| 1 | +$30.3M | |
| 2 | +$20.4M | |
| 3 | +$20.1M | |
| 4 |
BlackRock
New York
|
+$16.7M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$13.7M |
Top Sellers
| 1 | -$108M | |
| 2 | -$5.3M | |
| 3 | -$5.1M | |
| 4 |
Millennium Management
New York
|
-$4.38M |
| 5 |
HI
HBK Investments
Dallas,
Texas
|
-$4.21M |